Literature DB >> 34910811

Postoperative Management of Lung Transplant Recipients in the Intensive Care Unit.

Matteo Di Nardo1, Jussi Tikkanen2, Shahid Husain2, Lianne G Singer2, Marcelo Cypel2, Niall D Ferguson3, Shaf Keshavjee2, Lorenzo Del Sorbo4.   

Abstract

The number of lung transplantations is progressively increasing worldwide, providing new challenges to interprofessional teams and the intensive care units. The outcome of lung transplantation recipients is critically affected by a complex interplay of particular pathophysiologic conditions and risk factors, knowledge of which is fundamental to appropriately manage these patients during the early postoperative course. As high-grade evidence-based guidelines are not available, the authors aimed to provide an updated review of the postoperative management of lung transplantation recipients in the intensive care unit, which addresses six main areas: (1) management of mechanical ventilation, (2) fluid and hemodynamic management, (3) immunosuppressive therapies, (4) prevention and management of neurologic complications, (5) antimicrobial therapy, and (6) management of nutritional support and abdominal complications. The integrated care provided by a dedicated multidisciplinary team is key to optimize the complex postoperative management of lung transplantation recipients in the intensive care unit.
Copyright © 2021, the American Society of Anesthesiologists. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34910811     DOI: 10.1097/ALN.0000000000004054

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  2 in total

1.  Critical Care Management Following Lung Transplantation.

Authors:  Kyeongman Jeon
Journal:  J Chest Surg       Date:  2022-08-05

2.  The Impact of New Treatments on Short- and MID-Term Outcomes in Bilateral Lung Transplant: A Propensity Score Study.

Authors:  Annalisa Boscolo; Andrea Dell'Amore; Tommaso Pettenuzzo; Nicolò Sella; Alessandro De Cassai; Elisa Pistollato; Nicola Cacco; Andrea Manzan; Agnese De Carolis; Federico Geraldini; Giulia Lorenzoni; Federica Pezzuto; Giovanni Zambello; Marco Schiavon; Fiorella Calabrese; Dario Gregori; Emanuele Cozzi; Federico Rea; Paolo Navalesi
Journal:  J Clin Med       Date:  2022-10-03       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.